Could methylated reprimo cell-free DNA serve as a novel tumor marker to assess response in locally advanced gastric cancer treated with preoperative chemotherapy?

dc.creatorMuller, Gabriele Bettina
dc.creatorAlarcón, Alejandra
dc.creatorArancibia, Jorge M.
dc.creatorAlfaro, Francisca
dc.creatorSola, José Antonio
dc.creatorMaturana, María J.
dc.creatorAscui, Rodrigo Andrés
dc.creatorFernández, Wanda
dc.creatorCorvalán, Alejandro
dc.date.accessioned2015-09-28T19:05:52Z
dc.date.available2015-09-28T19:05:52Z
dc.date.created2015-09-28T19:05:52Z
dc.date.issued2015
dc.identifierJournal of Clinical Oncology Volumen: 33 Número: 3 Jan 20 2015
dc.identifierhttps://repositorio.uchile.cl/handle/2250/133921
dc.languageen
dc.publisherAmer Soc Clinical Oncology
dc.titleCould methylated reprimo cell-free DNA serve as a novel tumor marker to assess response in locally advanced gastric cancer treated with preoperative chemotherapy?
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución